{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:58:26Z","timestamp":1781283506797,"version":"3.54.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejso.2021.09.012","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T02:38:58Z","timestamp":1632191938000},"page":"492-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8307-6999","authenticated-orcid":false,"given":"Berend R.","family":"Beumer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Galjart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen L.A.","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-1039","authenticated-orcid":false,"given":"Jan N.M.","family":"IJzermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas Groot","family":"Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2021.09.012_bib1","first-page":"1","article-title":"The ALBI grade is a good predictive model for very late recurrence in patients with hepatocellular carcinoma undergoing primary resection","author":"Lin","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2021.09.012_bib2","first-page":"1","article-title":"Utilizing machine learning for pre-and postoperative assessment of patients undergoing resection for BCLC-0, A and B hepatocellular carcinoma: implications for resection beyond the BCLC guidelines","author":"Tsilimigras","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib3","first-page":"1420","article-title":"Establishment and validation of a prognostic model for hepatocellular carcinoma after radical liver resection","volume":"24","author":"Xue","year":"2019","journal-title":"Journal of BU ON.: official journal of the Balkan Union of Oncology"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12664-018-0915-0","article-title":"Staging systems of hepatocellular carcinoma: a review","volume":"37","author":"Tellapuri","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.ejso.2021.09.012_bib5","series-title":"Staging of hepatocellular carcinoma","author":"Karademir","year":"2018"},{"issue":"17","key":"10.1016\/j.ejso.2021.09.012_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4254\/wjh.v8.i17.703","article-title":"Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments","volume":"8","author":"Adhoute","year":"2016","journal-title":"World J Hepatol"},{"issue":"15","key":"10.1016\/j.ejso.2021.09.012_bib7","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.3748\/wjg.v20.i15.4141","article-title":"Staging systems of hepatocellular carcinoma: a review of literature","volume":"20","author":"Maida","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"issue":"Supplement 4","key":"10.1016\/j.ejso.2021.09.012_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1634\/theoncologist.2010-S4-23","article-title":"The challenge of prognosis and staging for hepatocellular carcinoma","volume":"15","author":"Marrero","year":"2010","journal-title":"Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2021.09.012_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ejso.2021.09.012_bib11","first-page":"218","article-title":"Diagnostic accuracy measures in cardiovascular research","volume":"29","author":"Borges","year":"2016","journal-title":"International Journal of Cardiovascular Sciences"},{"issue":"3","key":"10.1016\/j.ejso.2021.09.012_bib12","first-page":"40","article-title":"meta: an R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R\u00a0News"},{"key":"10.1016\/j.ejso.2021.09.012_bib13","series-title":"A\u00a0language and Environment for statistical Computing","author":"R Development Core Team","year":"2019"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.012_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-14-5","article-title":"Assessing discriminative ability of risk models in clustered data","volume":"14","author":"van Klaveren","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"10.1016\/j.ejso.2021.09.012_bib15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.012_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modelling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.012_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.ejso.2021.09.012_bib19","first-page":"1001","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib20","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib21","first-page":"561","article-title":"The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection","volume":"4","author":"Sheng","year":"2005","journal-title":"Hepatobiliary Pancreat Dis Int: HBPD INT"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib22","first-page":"491","article-title":"Staging of hepatocellular carcinoma","volume":"2","author":"Yan","year":"2003","journal-title":"Hepatobiliary Pancreat Dis Int: HBPD INT"},{"key":"10.1016\/j.ejso.2021.09.012_bib23","first-page":"67","article-title":"The consideration and proponent of the liver cancer staging classification","volume":"5","author":"Yang Bh","year":"1999","journal-title":"Chin J Hepatobiliary Surg"},{"key":"10.1016\/j.ejso.2021.09.012_bib24","series-title":"Seminars in liver disease","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","author":"Llovet","year":"1999"},{"key":"10.1016\/j.ejso.2021.09.012_bib25","series-title":"AJCC cancer staging handbook: TNM classification of malignant tumors","author":"Greene","year":"2002"},{"issue":"3","key":"10.1016\/j.ejso.2021.09.012_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s005350300038","article-title":"Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)","volume":"38","author":"Kudo","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejso.2021.09.012_bib27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejso.2004.05.003","article-title":"The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy","volume":"30","author":"Nanashima","year":"2004","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.sla.0000254368.65878.da","article-title":"Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC\/UICC TNM systems in a cohort of 13,772 patients in Japan","volume":"245","author":"Minagawa","year":"2007","journal-title":"Annals of surgery"},{"issue":"8","key":"10.1016\/j.ejso.2021.09.012_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00384-006-0259-6","article-title":"Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer","volume":"22","author":"McMillan","year":"2007","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3747\/co.v17i4.567","article-title":"The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer","volume":"17","author":"Kasymjanova","year":"2010","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jso.24908","article-title":"Critical evaluation of the American joint commission on cancer (AJCC) staging system for patients with hepatocellular carcinoma (HCC): a surveillance, epidemiology, end results (SEER) analysis","volume":"117","author":"Kamarajah","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib33","first-page":"4411","article-title":"A\u00a0new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy","volume":"15","author":"Tokumitsu","year":"2018","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.ejso.2021.09.012_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients","volume":"28","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib35","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.10384","article-title":"Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients","volume":"94","author":"Leung","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","article-title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer","volume":"89","author":"Forrest","year":"2003","journal-title":"British journal of cancer"},{"issue":"3","key":"10.1016\/j.ejso.2021.09.012_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/gut.2003.035055","article-title":"Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients","volume":"54","author":"Tateishi","year":"2005","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.ejso.2021.09.012_bib38","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/TP.0b013e31816b67e4","article-title":"Liver transplantation for hepatocellular carcinoma: hangzhou experiences","volume":"85","author":"Zheng","year":"2008","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.012_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jamcollsurg.2007.07.031","article-title":"A\u00a0novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma","volume":"206","author":"Cho","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.012_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00432-010-0935-3","article-title":"A\u00a0new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort","volume":"137","author":"Yang","year":"2011","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2021.09.012_bib41","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.012_bib42","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jamcollsurg.2015.08.003","article-title":"Prognostic nomograms for pre-and postoperative predictions of long-term survival for patients who underwent liver resection for huge hepatocellular carcinoma","volume":"221","author":"Li","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2021.09.012_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2016.04.011","article-title":"Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma","volume":"62","author":"Li","year":"2016","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/SLA.0000000000001339","article-title":"Nomograms for pre-and postoperative prediction of long-term survival for patients who underwent hepatectomy for multiple hepatocellular carcinomas","volume":"263","author":"Yang","year":"2016","journal-title":"Annals of surgery"},{"issue":"22","key":"10.1016\/j.ejso.2021.09.012_bib45","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4103\/0366-6999.218019","article-title":"Shanghai score: a prognostic and adjuvant treatment-evaluating system constructed for Chinese patients with hepatocellular carcinoma after curative resection","volume":"130","author":"Sun","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.ejso.2021.09.012_bib46","series-title":"Novel prognostic nomograms based on Inflammation-related markers for patients with hepatocellular carcinoma underwent Hepatectomy","author":"Wang","year":"2019"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118658","article-title":"The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma","volume":"10","author":"Ang","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.012_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/SLA.0000000000000747","article-title":"Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma","volume":"261","author":"Shim","year":"2015","journal-title":"Annals of surgery"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib49","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","article-title":"Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"69","author":"Chan","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2021.09.012_bib50","series-title":"A\u00a0novel score predicts HBV-related hepatocellular carcinoma recurrence after Hepatectomy: a retrospective multicenter study","author":"Qin","year":"2018"},{"issue":"9","key":"10.1016\/j.ejso.2021.09.012_bib51","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.ejso.2019.03.043","article-title":"A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: a large-scale, multicenter study","volume":"45","author":"Zhang","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib52","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejso.2006.10.012","article-title":"Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy","volume":"33","author":"Chen","year":"2007","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib53","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00534-009-0096-4","article-title":"Usefulness of the CLIP scoring system for prediction of postoperative prognosis of patients with large hepatocellular carcinoma","volume":"16","author":"Noda","year":"2009","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"issue":"41","key":"10.1016\/j.ejso.2021.09.012_bib54","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.3748\/wjg.v16.i41.5257","article-title":"Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery","volume":"16","author":"Xu","year":"2010","journal-title":"World J Gastroenterol: WJG"},{"issue":"10","key":"10.1016\/j.ejso.2021.09.012_bib55","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00432-013-1497-y","article-title":"A\u00a0modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy","volume":"139","author":"Huang","year":"2013","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejso.2021.09.012_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-52","article-title":"The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma","volume":"13","author":"Kinoshita","year":"2013","journal-title":"BMC Canc"},{"issue":"8","key":"10.1016\/j.ejso.2021.09.012_bib57","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ejso.2013.05.001","article-title":"External validation of a simplified BCLC staging system for early hepatocellular carcinoma","volume":"39","author":"Santambrogio","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-014-0883-x","article-title":"The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy","volume":"31","author":"Huang","year":"2014","journal-title":"Med Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2021.09.012_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103228","article-title":"Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"issue":"38","key":"10.1016\/j.ejso.2021.09.012_bib60","doi-asserted-by":"crossref","first-page":"61378","DOI":"10.18632\/oncotarget.11358","article-title":"Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1","volume":"7","author":"Ruan","year":"2016","journal-title":"Oncotarget"},{"issue":"49","key":"10.1016\/j.ejso.2021.09.012_bib61","doi-asserted-by":"crossref","first-page":"80783","DOI":"10.18632\/oncotarget.13038","article-title":"Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics","volume":"7","author":"Shen","year":"2016","journal-title":"Oncotarget"},{"issue":"36","key":"10.1016\/j.ejso.2021.09.012_bib62","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.3748\/wjg.v22.i36.8194","article-title":"Development of a prognostic scoring system for resectable hepatocellular carcinoma","volume":"22","author":"Sposito","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.012_bib63","first-page":"8272","article-title":"Comparison of the prognostic value of C-reactive protein-based prognostic scores in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"9","author":"Wang","year":"2016","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib64","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/SLA.0000000000001339","article-title":"Nomograms for pre- and postoperative prediction of long-term survival for patients who underwent hepatectomy for multiple hepatocellular carcinomas","volume":"263","author":"Yang","year":"2016","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.012_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00432-016-2286-1","article-title":"Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma","volume":"143","author":"Feng","year":"2017","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.09.012_bib66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1634\/theoncologist.2016-0231","article-title":"Prognostic nomograms stratify survival of patients with hepatocellular carcinomawithout portal vein tumor thrombosis after curative resection","volume":"22","author":"Fu","year":"2017","journal-title":"Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.012_bib67","first-page":"2574","article-title":"Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma","volume":"15","author":"Cao","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejso.2021.09.012_bib68","first-page":"5383","article-title":"Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with child\u2013pugh I who underwent curative resection: a prognostic nomogram study","volume":"10","author":"Gan","year":"2018","journal-title":"Canc Manag Res"},{"key":"10.1016\/j.ejso.2021.09.012_bib69","series-title":"Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection","author":"Hu","year":"2018"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib70","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jso.24895","article-title":"A\u00a0novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection","volume":"117","author":"Huang","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2021.09.012_bib71","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s11605-018-3810-1","article-title":"Combined preoperative ALBI and FIB-4 is associated with recurrence of hepatocellular carcinoma after curative hepatectomy","volume":"22","author":"Liao","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib72","first-page":"4411","article-title":"A\u00a0new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy","volume":"15","author":"Tokumitsu","year":"2018","journal-title":"Oncology letters"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.012_bib73","article-title":"Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Cancser"},{"key":"10.1016\/j.ejso.2021.09.012_bib74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.suronc.2019.05.017","article-title":"A\u00a0simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: an implication for adjuvant therapy and postoperative surveillance","volume":"30","author":"Ng","year":"2019","journal-title":"Surgical Oncology"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.012_bib75","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/apt.15074","article-title":"A\u00a0modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria","volume":"49","author":"Wang","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib76","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5009\/gnl18489","article-title":"Novel prognostic nomograms for hepatocellular carcinoma patients with microvascular invasion: experience from a single center","volume":"13","author":"Xu","year":"2019","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.012_bib78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0272989X8300300211","article-title":"Use of the hazard rate to schedule follow-up exams efficiently: an optimization approach to patient management","volume":"3","author":"Dwyer","year":"1983","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ejso.2021.09.012_bib79","doi-asserted-by":"crossref","first-page":"i2416","DOI":"10.1136\/bmj.i2416","article-title":"Prediction models for cardiovascular disease risk in the general population: systematic review","volume":"353","author":"Damen","year":"2016","journal-title":"bmj"},{"key":"10.1016\/j.ejso.2021.09.012_bib80","doi-asserted-by":"crossref","first-page":"b606","DOI":"10.1136\/bmj.b606","article-title":"Prognosis and prognostic research: application and impact of prognostic models in clinical practice","volume":"338","author":"Moons","year":"2009","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.012_bib81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000449344","article-title":"Surgery and hepatocellular carcinoma","volume":"6","author":"Akamatsu","year":"2017","journal-title":"Liver cancer"},{"issue":"2","key":"10.1016\/j.ejso.2021.09.012_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000342403","article-title":"Liver resection and transplantation in hepatocellular carcinoma","volume":"1","author":"Belghiti","year":"2012","journal-title":"Liver cancer"},{"issue":"4","key":"10.1016\/j.ejso.2021.09.012_bib83","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jamcollsurg.2014.12.030","article-title":"Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?","volume":"220","author":"Chapman","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.012_bib84","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejso.2021.09.012_bib85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2019.10.001","article-title":"Use of a novel index, the A-index, and its associated nomogram to predict overall survival rates after resection of primary hepatocellular carcinoma","volume":"500","author":"Cai","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejso.2021.09.012_bib86","unstructured":"Lin, Z.-X., et\u00a0al., Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy. Clin Transl Oncol: p. 1-11."},{"issue":"1","key":"10.1016\/j.ejso.2021.09.012_bib87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"Journal of hepatology"},{"issue":"Supplement_4","key":"10.1016\/j.ejso.2021.09.012_bib88","doi-asserted-by":"crossref","first-page":"iv238","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.09.012_bib89","volume":"381","author":"Steyerberg","year":"2009"},{"issue":"6","key":"10.1016\/j.ejso.2021.09.012_bib90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"issue":"1","key":"10.1016\/j.ejso.2021.09.012_bib91","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:13:20Z","timestamp":1781280800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321007381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0748798321007381"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.09.012","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}